IL2 and psoriasis: Given that the anti-IL-2/IL-12 complex is considered an immune modulator for antigen-activated lymphocyte proliferation, this study aimed to compare the immunophenotypic, clinical, and histological effect of anti-IL2/IL-2 complex with a low dose of IL-2 on psoriasis-like skin inflammation induced by imiquimod.